MARKET

PFE

PFE

Pfizer
NYSE

Real-time Quotes | Nasdaq Last Sale

38.32
+0.03
+0.08%
After Hours: 38.32 0 0.00% 18:55 12/09 EST
OPEN
38.10
PREV CLOSE
38.29
HIGH
38.38
LOW
38.10
VOLUME
14.97M
TURNOVER
--
52 WEEK HIGH
44.90
52 WEEK LOW
33.97
MARKET CAP
212.07B
P/E (TTM)
14.10
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PFE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PFE News

  • Former lobbyist and Biden's current campaign chairman is helping raise cash for the former VP
  • CNBC.com.6h ago
  • Flagging French Drug Giant Tries a Familiar Remedy
  • Bloomberg.7h ago
  • Sanofis New CEO Is Aiming for a Narrower Focus in Drug Development
  • Barrons.com.9h ago
  • Biotech stocks are producing outsized gains — here’s how to get your share
  • MarketWatch.9h ago

More

Industry

Pharmaceuticals
+0.14%
Pharmaceuticals & Medical Research
+0.23%

Hot Stocks

Name
Price
%Change

About PFE

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
More

Webull offers Pfizer Inc. (PFE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.